India tests vaccine delivery systems ahead of emergency approval
AHMEDABAD, India (Reuters) - Some Indian states on Monday began a trial run of COVID-19 vaccine delivery systems, with health authorities checking everything from their technology platforms to the storage infrastructure that will be required to inoculate millions.
India wants to deliver 600 million coronavirus shots in the next six to eight months starting in January, with emergency use approval for the Oxford/AstraZeneca vaccine expected within days.